Asvapo SRL
Asvapo reported total assets of €1.22m at the end of the 2025 financial year (annual accounts filed with the NBB on 25 Mar 2026).
The score of Asvapo shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +34 % Total assets +517 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Asvapo's annual accounts
Filed annual accounts
- Year ended 30 Sep 2025filed on 25 Mar 2026
- Year ended 30 Sep 2024filed on 18 Apr 2025
- Year ended 30 Sep 2023filed on 08 Apr 2024
- Year ended 30 Sep 2022filed on 04 Apr 2023
- Year ended 30 Sep 2021filed on 29 Apr 2022
Asvapo's financial analysis
- Solvency20.3%sector median: 44.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Asvapo
Asvapo's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0849.980.217
- VAT number
- BE0849980217
- Peppol
- Registered · 0208:0849980217 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 11 Oct 2012
- Registered office
- 8501 Kortrijk
- Latest accounts
- 2025 · filed on 25 Mar 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Asvapo (SRL) has been based in Kortrijk since 2012, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 21,473 € and equity of 247,347 €; its revenue is not published. Its solvency stands at 20.3%, below the median of its sector (44.0%).
Companies similar to Asvapo
Companies in the same business, of comparable size and area, outside its group.
- Decopharma Retail sale of pharmaceutical products Sint-Niklaas · balance sheet €1.36m
- DE Spiegeleere - Discart Retail sale of pharmaceutical products Braine-l'Alleud · balance sheet €1.36m
- Pharmacie DE Neef - Duez Retail sale of pharmaceutical products Mons · balance sheet 181,026 €
- Apotheek Opsomer Retail sale of pharmaceutical products Poperinge · balance sheet €1.22m
- Racha NAIM Retail sale of pharmaceutical products Saint-Nicolas · balance sheet €1.21m
- EASI Retail sale of pharmaceutical products Ciney · balance sheet €1.24m
- Sanifar Retail sale of pharmaceutical products Ghent · balance sheet €1.24m
- Ritzen Anouk Retail sale of pharmaceutical products Keerbergen · balance sheet €1.25m
Frequently asked questions about Asvapo
What is the revenue of Asvapo?
Asvapo files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Asvapo?
In Belgium, the VAT number is the company number prefixed with BE: BE0849980217 for Asvapo, if the company is VAT-registered. Its company number (CBE) is 0849.980.217.
Where is the registered office of Asvapo?
According to the CBE register, the registered office of Asvapo is in 8501 Kortrijk.
What is the equity of Asvapo?
At the close of the 2025 financial year, the equity of Asvapo amounts to 247,347 €, a solvency of 20.3% of total assets.
Who manages Asvapo?
The register lists 1 active mandates at Asvapo. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Asvapo
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →